3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma

BACKROUND: Radiolabeled OTSA101, a monoclonal antibody targeting synovial sarcoma (SS) developed by OncoTherapy Science, was used to treat relapsing SS metastases following a theranostic procedure: in case of significant (111)In-OTSA101 tumor uptake and favorable biodistribution, patient was randoml...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarrut, David, Badel, Jean-Noël, Halty, Adrien, Garin, Gwenaelle, Perol, David, Cassier, Philippe, Blay, Jean-Yves, Kryza, David, Giraudet, Anne-Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241566/
https://www.ncbi.nlm.nih.gov/pubmed/28101733
http://dx.doi.org/10.1186/s40658-016-0172-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241566/
https://www.ncbi.nlm.nih.gov/pubmed/28101733
http://dx.doi.org/10.1186/s40658-016-0172-1

Ejemplares similares